AnHeart Therapeutics Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Zhejiang, China (2018)

Organization Overview

First Clinical Trial
2020
NCT04395677
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

AnHeart Therapeutics Inc.